Related Experiment Video
Updated: Jul 31, 2026
10:10
Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells
Published on: October 27, 2009
Mechanism of epinephrine-induced platelet aggregation
A Spalding1, H Vaitkevicius, S Dill
1Wayne State University School of Medicine, Veterans Administration Medical Center, Detroit, Mich 48201, USA.
Hypertension (Dallas, Tex. : 1979)
|February 14, 1998
Summary
Genetic differences in chloride transport influence epinephrine-mediated platelet aggregation, a key factor in hypertension. Blocking chloride transport may offer protection against vascular thrombosis in hypertensive patients.
Area of Science:
- Cardiovascular Biology
- Platelet Physiology
- Pharmacology
Background:
- A genetic polymorphism in the alpha2-adrenergic receptor (A2AR) is linked to hypertension and increased epinephrine-mediated platelet aggregation.
- The underlying mechanism for this heritable difference in epinephrine sensitivity remains unclear.
Purpose of the Study:
- To investigate the hypothesis that epinephrine-induced platelet aggregation is mediated by chloride transport.
- To explore the role of chloride transport in the synergistic effect of epinephrine on thrombin-induced platelet aggregation.
Main Methods:
- Platelet aggregation was measured using optical density in response to epinephrine.
- The effects of chloride transport inhibitors (bumetanide, anthracene-9-carboxylic acid, acetazolamide) on aggregation were assessed.
- Intraplatelet chloride concentrations were measured fluorometrically.
- A2AR ligand binding and platelet cAMP levels were analyzed.
Main Results:
- Inhibitors of Na/K/2Cl cotransport, chloride channels, and ATP-dependent chloride transport significantly reduced epinephrine-mediated platelet aggregation.
- Epinephrine significantly increased intraplatelet chloride concentrations.
- Chloride transport blockade diminished the potentiation of thrombin-induced platelet aggregation by epinephrine.
- These effects were independent of A2AR binding or cAMP levels.
Conclusions:
- Heritable variations in platelet chloride transport likely contribute to differences in epinephrine-mediated platelet aggregation.
- Chloride transport is essential for epinephrine-induced platelet aggregation.
- Pharmacological agents blocking chloride transport, such as diuretics, may offer vascular protection in hypertensive individuals by inhibiting platelet aggregation, independent of their blood pressure effects.
Related Concept Videos
01:09GPCRs Regulate Adenylyl Cylase Activity
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Two...
01:25cAMP-dependent Protein Kinase Pathways
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
01:28Adrenergic Agonists: Mixed-Action Agents
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
01:16Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:22Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...